UBS Group Raises Olin (NYSE:OLN) Price Target to $58.00

Olin (NYSE:OLNGet Free Report) had its price objective boosted by equities researchers at UBS Group from $56.00 to $58.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price target suggests a potential upside of 4.81% from the company’s current price.

OLN has been the topic of a number of other reports. Piper Sandler lowered their price target on shares of Olin from $70.00 to $60.00 and set an “overweight” rating on the stock in a report on Wednesday, October 11th. Stifel Nicolaus lowered their target price on shares of Olin from $66.00 to $65.00 and set a “buy” rating for the company in a research note on Monday, October 30th. StockNews.com assumed coverage on shares of Olin in a research note on Thursday, October 5th. They issued a “hold” rating for the company. JPMorgan Chase & Co. cut shares of Olin from an “overweight” rating to a “neutral” rating and lowered their target price for the stock from $75.00 to $48.00 in a research note on Monday, October 30th. Finally, Barclays decreased their price objective on shares of Olin from $52.00 to $46.00 and set an “equal weight” rating for the company in a research note on Monday, October 30th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $55.27.

View Our Latest Stock Analysis on OLN

Olin Stock Up 6.9 %

Shares of NYSE:OLN traded up $3.59 during trading on Friday, reaching $55.34. The stock had a trading volume of 1,737,828 shares, compared to its average volume of 1,045,687. Olin has a one year low of $41.71 and a one year high of $64.70. The company has a market capitalization of $6.78 billion, a P/E ratio of 12.22, a PEG ratio of 8.68 and a beta of 1.47. The company has a current ratio of 1.50, a quick ratio of 0.80 and a debt-to-equity ratio of 1.15. The firm’s 50-day simple moving average is $50.92 and its 200 day simple moving average is $51.05.

Olin (NYSE:OLNGet Free Report) last released its quarterly earnings results on Friday, October 27th. The specialty chemicals company reported $0.82 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.15. Olin had a net margin of 8.39% and a return on equity of 24.36%. The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.73 billion. During the same period last year, the business earned $2.18 EPS. The company’s revenue was down 28.0% compared to the same quarter last year. As a group, research analysts expect that Olin will post 3.33 EPS for the current fiscal year.

Institutional Investors Weigh In On Olin

Hedge funds have recently modified their holdings of the company. CWM LLC boosted its stake in Olin by 6.4% during the second quarter. CWM LLC now owns 3,166 shares of the specialty chemicals company’s stock worth $163,000 after buying an additional 190 shares during the period. Arbor Capital Management Inc. ADV boosted its stake in shares of Olin by 0.5% in the first quarter. Arbor Capital Management Inc. ADV now owns 38,729 shares of the specialty chemicals company’s stock valued at $2,224,000 after purchasing an additional 199 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of Olin by 0.5% in the second quarter. Price T Rowe Associates Inc. MD now owns 42,285 shares of the specialty chemicals company’s stock valued at $1,957,000 after purchasing an additional 216 shares during the period. Captrust Financial Advisors boosted its stake in shares of Olin by 3.3% in the third quarter. Captrust Financial Advisors now owns 6,834 shares of the specialty chemicals company’s stock valued at $293,000 after purchasing an additional 217 shares during the period. Finally, Ritholtz Wealth Management boosted its stake in shares of Olin by 1.5% in the fourth quarter. Ritholtz Wealth Management now owns 16,389 shares of the specialty chemicals company’s stock valued at $884,000 after purchasing an additional 238 shares during the period. Hedge funds and other institutional investors own 85.69% of the company’s stock.

Olin Company Profile

(Get Free Report)

Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.

Further Reading

Analyst Recommendations for Olin (NYSE:OLN)

Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.